Showing results (1-10 of 109) with videos related to
Sort By:
Pageof 11
Clinical Neuropharmacology|February 27, 1999
The effect of deprenyl treatment on directional and velocity control of arm movement in patients with early stages of Parkinson's diseaseN Giladi, S Honigman, S HochermanHarefuah|January 14, 1999
[Botulinum toxin injection effective for post-peripheral facial nerve palsy synkinesis]S Badarny, N Giladi, S HonigmanEuropean Neurology|October 29, 2000
Long-term remission of idiopathic cervical dystonia after treatment with botulinum toxinN Giladi, J Meer, H Kidan, et al.Harefuah|December 1, 1993
[Botulinum toxin for palatal myoclonus and spastic dysphonia]E Greenberg, N Giladi, J Meer, et al.Israel Journal of Medical Sciences|November 1, 1994
Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurologyN Giladi, J Meer, C Kidan, et al.Clinical Neuropharmacology|December 17, 2004
Tetrabenazine treatment in movement disordersD Paleacu, N Giladi, O Moore, et al.Israel Journal of Medical Sciences|February 1, 1997
The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy--a pilot studyN Zelnik, N Giladi, I Goikhman, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 19, 2001
Gastric emptying time and gastric motility in patients with Parkinson's diseaseR Hardoff, M Sula, A Tamir, et al.Journal of the Neurological Sciences|February 7, 1998
The mechanism of action of botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected siteN GiladiPageof 11